Strongbridge Biopharma PLC EBITDA 2016-2021 | SBBP
Strongbridge Biopharma PLC ebitda from 2016 to 2021. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Strongbridge Biopharma PLC Annual EBITDA (Millions of US $) |
|
|---|---|
| 2020 | $-38 |
| 2019 | $-62 |
| 2018 | $-75 |
| 2017 | $-69 |
| 2016 | $-51 |
| 2015 | $-43 |
| 2014 | $-10 |
| 2013 | $-5 |
| Strongbridge Biopharma PLC Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2021-06-30 | $-12 |
| 2021-03-31 | $-9 |
| 2020-12-31 | $-9 |
| 2020-09-30 | $-8 |
| 2020-06-30 | $-8 |
| 2020-03-31 | $-12 |
| 2019-12-31 | $-15 |
| 2019-09-30 | $-16 |
| 2019-06-30 | $-15 |
| 2019-03-31 | $-16 |
| 2018-12-31 | $-21 |
| 2018-09-30 | $-23 |
| 2018-06-30 | $-17 |
| 2018-03-31 | $-14 |
| 2017-12-31 | $-13 |
| 2017-09-30 | $-32 |
| 2017-06-30 | $-13 |
| 2017-03-31 | $-11 |
| 2016-12-31 | $-18 |
| 2016-09-30 | $-8 |
| 2016-06-30 | $-14 |
| 2016-03-31 | $-11 |
| 2015-12-31 | $-10 |
| 2015-09-30 | $-10 |
| 2015-06-30 | $-17 |
| 2015-03-31 | $-6 |
